SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): A novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 6, 1996, Pages 505-508

  Panasci, Lawrence C ^a   Marcantonio, Daniela ^a   Noë, Adrian J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Catecholamine; Chloroethylnitrosourea; Cytotoxicity; SarCNU

Indexed keywords

2 CHLOROETHYL 3 SARCOSINAMIDE 1 NITROSOUREA; ADRENALIN; CARMUSTINE; CHLOROETHYLNITROSOUREA DERIVATIVE; NORADRENALIN; SARCOSINAMIDE; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CATECHOLAMINE UPTAKE; CYTOTOXICITY; DRUG TRANSPORT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL TRANSPORT; CARMUSTINE; CARRIER PROTEINS; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; CATECHOLAMINES; HUMANS; MEMBRANE TRANSPORT PROTEINS; SARCOSINE; TUMOR CELLS, CULTURED;

EID: 0029920660     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050421     Document Type: Review

References (19)

1. Begleiter A, Lam H-YP, Goldenberg G J (1977) Mechanism of uptake of nitrosourea by L5178Y lymphoblasts in vitro. Cancer Res 37: 1022
2. Carter KS, Schabel TM Jr, Broler LE, Jonston TP (1972) 1,3-bis-(2-Chloroethyl)-1-nitrosourea (BCNU) and other nitrosoureas in cancer treatment: a review. Adv Cancer Res 16: 273
3. Hoff DD von, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF (1983) Prospective clinical trial of a human tumour cloning system. Cancer Res 43: 1926
4. Houchens D, Sheridan M, Nines R, Finfrock M, Trigg N (1989) Glioma and medulloblastoma xenografts as models for brain tumour drug development. In: The Sixth International Workshop on Immunodeficient Animals. Karger Publishing, Basel, Switzerland, p 157
5. Ludlum DB, Tong WP (1981) Modification of DNA and RNA bases. In: Prestayko AW, Crooke ST, Baker LH, Carter SK, Schein PS (eds) Nitrosoureas, current status and development. Academic Press, New York, p 85
6. 3H-adrenaline in the rabbit aorta. Naunyn Schmiedebergs Arch Pharmacol 347: 363
7. Noë AJ, Malapetsa A, Panasci LC (1993) Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell line, SK-MG-1, is mediated by an epinephrine sensitive carrier system. Mol Pharmacol 44: 204
8. Noë AJ, Malapetsa A, Panasci LC (1994) Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics. Cancer Res 54: 1491
9. Panasci LC, Dufour M, Chevalier L, Isabel G, Lazarus P, McQuillan A, Arbit E, Brem S, Feindel W (1985) Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human gliomas compared with BCNU. Cancer Chemother Pharmacol 14: 156
10. 2) in a human cell line (Caki-1 cells). Naunyn Schmiedebergs Arch Pharmacol 341: 404
11. Sheithauer W, Clark GM, Salmon SE, Dorda W, Shoemaker RH, Hoff DD von (1986) Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man. Cancer Treat Rep 70: 1379
12. Skalski V, Rivas J, Panasci LC, Feindel W (1988) The cytotoxicity of sarcosinamide chloroethylnitrosourea (SarCNU) and BCNU in primary gliomas and glioma cell lines: analysis of data in reference to theoretical peak plasma concentrations in man. Cancer Chemother Pharmacol 22: 137
13. Skalski V, Feindel W, Panasci LC (1989) The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport. J Neurooncol 7: 189
14. Skalski V, Feindel W, Panasci LC (1990) Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cells. Cancer Res 50: 3062
15. Suami T, Kato T, Hisamatsu T (1982) 2-Chloroethylnitrosourea congeners of amino acid amides. J Med Chem 25: 829
16. Walker MD (1975) Chemotherapy: adjuvant to surgery and radiation therapy. Semin Oncol 2: 69
17. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiation in the treatment of anaplastic gliomas. A comparative clinical trial. J Neurosurg 49: 333
18. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf, Mealy J, Owens G, Ransohoff J II, Roberston JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiation and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323
19. Wheeler GP, Bowden BJ, Struck RF (1975) Carbamoylation of amino acids, peptides and proteins by nitrosoureas. Cancer Res 35: 2974